Joshua R. Disbrow
2022 - AYTU BIOPHARMA
In 2022, Joshua R. Disbrow earned a total compensation of $590K as Chairman and Chief Executive Officer since December at AYTU BIOPHARMA, a 90% decrease compared to previous year.
Compensation breakdown
| Salary | $590,000 |
|---|---|
| Total | $590,000 |
Disbrow received $590K in salary, accounting for 100% of the total pay in 2022.
Rankings
In 2022, Joshua R. Disbrow's compensation ranked 4,073rd out of 5,676 executives tracked by ExecPay. In other words, Disbrow earned more than 28.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,073 out of 5,676 | 28th |
Division Manufacturing | 2,298 out of 3,084 | 26th |
Major group Chemicals And Allied Products | 1,115 out of 1,399 | 20th |
Industry group Drugs | 1,046 out of 1,300 | 20th |
Industry Pharmaceutical Preparations | 761 out of 942 | 19th |
Source: SEC filing on May 10, 2024.
Disbrow's colleagues
We found one more compensation record of an executive who worked with Joshua R. Disbrow at AYTU BIOPHARMA in 2022.
2022
Mark Oki
AYTU BIOPHARMA
Chief Financial Officer
News
AYTU BIOPHARMA CEO Joshua Disbrow's 2023 pay rises 20% to $708K
May 10, 2024
AYTU BIOPHARMA CEO Joshua Disbrow's 2021 pay jumps 291% to $6.2M
April 7, 2022
AYTU BIOPHARMA CEO Joshua Disbrow's 2020 pay jumps 52% to $1.6M
April 16, 2021
AYTU BIOPHARMA CEO Joshua Disbrow's 2019 pay jumps 72% to $1M
March 5, 2020
AYTU BIOPHARMA CEO Joshua Disbrow's 2018 pay falls 42% to $606K
February 25, 2019